Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$1.06 - $1.67 $27,693 - $43,630
26,126 New
26,126 $30,000
Q3 2023

Nov 13, 2023

BUY
$1.61 - $2.54 $23,489 - $37,058
14,590 New
14,590 $26,000
Q1 2022

May 13, 2022

SELL
$2.83 - $8.69 $12.7 Million - $39.1 Million
-4,500,100 Closed
0 $0
Q4 2021

Feb 11, 2022

SELL
$8.31 - $14.92 $33.7 Million - $60.4 Million
-4,050,000 Reduced 47.37%
4,500,100 $37.4 Million
Q3 2021

Nov 12, 2021

BUY
$9.15 - $13.28 $78.2 Million - $114 Million
8,550,100 New
8,550,100 $99.1 Million

Others Institutions Holding DNA

About Ginkgo Bioworks Holdings, Inc.


  • Ticker DNA
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 1,287,779,968
  • Market Cap $12.1B
  • Description
  • Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agric...
More about DNA
Track This Portfolio

Track Franklin Resources Inc Portfolio

Follow Franklin Resources Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.